Diagnostic Traps in Papillary Thyroid Carcinoma: Correlation of The Bethesda System for Reporting Thyroid Cytopathology with Histopathology: A Case Series
DOI:
https://doi.org/10.21276/apalm.3668Keywords:
bethesda, cytology, thyroid, papillary carcinoma, follicular variant, niftpAbstract
Fine-needle aspiration cytology is a widely used first-line tool for evaluating thyroid lesions, with histopathology serving as the diagnostic gold standard. Despite its advantages, interpretation challenges arise due to overlapping cytomorphologic features, suboptimal sample adequacy, and inter-observer variability, occasionally leading to discordance and affecting patient management. This case series describes four diagnostically challenging cases of classical papillary thyroid carcinoma in which initial cytological interpretations differed from final histopathological findings. Each case was re-evaluated systematically with emphasis on adequacy of the aspirate, radiologic correlation, characteristic cytological features, and potential diagnostic pitfalls. Contributing factors such as papillary hyperplasia mimics, misleading ultrasound impressions, and low cellularity were analyzed to understand the basis of discordance. Final diagnoses were established through multidisciplinary collaboration among the surgeon, radiologist, and cytopathologist. Case 1 was initially reported as a benign colloid nodule (TBSRTC II) but was later confirmed as classical papillary carcinoma with nodal metastasis. Case 2 was categorized as AUS (TBSRTC III); histopathology revealed classical papillary carcinoma, infiltrating follicular subtype. Case 3 was diagnosed as follicular neoplasm (TBSRTC IV) on cytology, while final evaluation confirmed NIFTP. Case 4, also categorized as follicular neoplasm (TBSRTC IV), was ultimately diagnosed as encapsulated angioinvasive follicular variant of papillary thyroid carcinoma. TBSRTC remains a robust and standardized framework for thyroid cytology, providing consistent terminology and risk stratification. However, diagnostic limitations persist, emphasizing the need for meticulous cytologic assessment, close radiologic correlation, and interdisciplinary collaboration to minimize discordance and improve patient outcomes.References
1.Kamboj M, Mehta A, Pasricha S, Gupta G, Sharma A, Durga G. Cytomorphological categorization of thyroid lesions according to the Bethesda system for reporting thyroid cytology and correlation with their histological outcome: an Indian oncology centre experience. Journal of Cytology. 2022 Jan 1;39(1):44-50.
2.Kim JY, Kim EK, Lee HS, Kwak JY. Conventional papillary thyroid carcinoma: effects of cystic changes visible on ultrasonography on disease prognosis. Ultrasonography. 2014 Aug 11;33(4):291.
3.Fortuna GM, Rios P, Rivero A, Zuniga G, Dvir K, Pagacz MM, Manzano A. Papillary thyroid carcinoma with cystic changes in a patient with prior history of toxic nodule. Journal of Investigative Medicine High Impact Case Reports. 2020 Jul;8:2324709620942672
4.Harahap AS, Jung CK. Cytologic hallmarks and differential diagnosis of papillary thyroid carcinoma subtypes. Journal of Pathology and Translational Medicine. 2024 Nov 1;58(6):265-82..
5.Pusztaszeri M, Auger M. Update on the cytologic features of papillary thyroid carcinoma variants. Diagnostic cytopathology. 2017 Aug;45(8):714-30.
6.Yang GC, Fried KO, Scognamiglio T. Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: a review of 179 cases. Diagnostic cytopathology. 2017 Jun;45(6):533-41.
7.Macerola E, Proietti A, Basolo F. Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a new entity. Gland Surgery. 2020 Jan;9(Suppl 1):S47.
8.Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO classification of tumours of endocrine organs: WHO classification of tumours. International Agency for Research on Cancer: Lyon, French. 2017.
9.WHO classification of tumours of endocrine organs. 5th beta ed. [Internet]. Geneva: World Health Organization, 2022 [cited 2024 https://doi.org/10.4132/jptm.2024.09.14 49 Nguyen TP-X et al. May 20]. Available from: https://tumourclassification.iarc.who. int.
10. Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 2022; 33: 27- 63
11.Nguyen TP, Le MK, Roytrakul S, Shuangshoti S, Kitkumthorn N, Keelawat S. Diagnosis of invasive encapsulated follicular variant papillary thyroid carcinoma by protein-based machine learning. Journal of Pathology and Translational Medicine. 2024 Oct 24;59(1):39.
12.Ali SZ, VanderLaan PA, editors. The Bethesda system for reporting thyroid cytopathology: definitions, criteria, and explanatory notes. Springer Nature; 2023 Jun 29.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Bindhuja Joseph, Arya Prakash, Kitty J Kuruvilla

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
